ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,973Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 623

$503K Total Retail Price of All Prescriptions

Rank: 37 out of 623

485 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 485 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 5,878 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 374 232 1 1
AMLODIPINE BESYLATE 357 252 2 3
GABAPENTIN 259 125 3 18
SIMVASTATIN 257 200 4 2
FUROSEMIDE 254 184 5 5
OMEPRAZOLE 253 185 6 7
PRAVASTATIN SODIUM 202 142 7 11
HYDROCODONE-ACETAMINOPHEN 196 50 S3 8 17
CITALOPRAM HBR 195 134 9 21
METFORMIN HCL 175 93 10 6
LEVOTHYROXINE SODIUM 168 134 11 4
GLIPIZIDE 161 102 12 33
TRAMADOL HCL 158 73 13 15
METOPROLOL TARTRATE 146 110 14 9
HYDROCHLOROTHIAZIDE 144 98 15 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 98 16 19
ZOLPIDEM TARTRATE 137 66 17 22
TRAZODONE HCL 136 96 18 36
ATENOLOL 134 94 19 12
ATORVASTATIN CALCIUM 114 71 20 10
ISOSORBIDE MONONITRATE ER 112 92 21 64
WARFARIN SODIUM 101 57 22 14
RANITIDINE HCL 92 64 23 23
SERTRALINE HCL 88 77 24 20
POTASSIUM CHLORIDE 87 55 25 24
PANTOPRAZOLE SODIUM 85 67 26 26
FENTANYL 80 40 S2 27 76
PREDNISONE 76 52 28 40
TAMSULOSIN HCL 72 49 29 35
CARVEDILOL 71 44 30 32
HYDRALAZINE HCL 68 60 31 70
MIRTAZAPINE 67 53 32 31
PROAIR HFA 66 26 33 57
FLUTICASONE PROPIONATE 62 37 34 29
ALLOPURINOL 61 41 35 44
NEXIUM 59 42 36 43
LOSARTAN POTASSIUM 56 47 37 16
ESCITALOPRAM OXALATE 55 28 38 60
DIOVAN 53 32 39 48
IBUPROFEN 52 13 40 68
DONEPEZIL HCL 51 51 41 27
NAMENDA 51 51 41 47
CLOPIDOGREL 50 21 43 34
METOPROLOL SUCCINATE 50 38 43 13
CYCLOBENZAPRINE HCL 50 13 R 43 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.